ACTRIMS 2022 – Clinical Trial Design and the Use of Novel Patient Recruitment Strategy
Dr. Allitia DiBernardo, M.D., Vice President, Global Medical Affairs, Neuroscience, Global Commercial Strategy Organization (GCSO) at Janssen discusses a novel patient recruitment strategy for patients with multiple sclerosis that was presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS ®) 2022 meeting. Janssen will be utilizing up-front matching to assign patients treatments as if they were being randomized to treatment. This unique design tactic is especially of value for studies whose results become part of the evidence for regulatory decision-making to be more credible with the potential for significant cost efficiencies in generating the data.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Treatment. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Treatment and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Treatment?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
With over 22 years of experience in the field, I am passionate about understanding and shining a light on the lived experiences of individuals with neurologic disorders. As the Global Head of Medial Affairs, Neurology at Janssen, I have the honor of channeling that passion into leading an incredible team that is actively working to bring new therapies to patients with CNS disorders, leading the way in neurology research.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
